---
title: Prospective study validating a multidimensional treatment decision score predicting
  the 24-month outcome in untreated patients with clinically isolated syndrome and
  early relapsing-remitting multiple sclerosis, the ProVal-MS study
date: '2024-03-06'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/38449051/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20240307170638&v=2.18.0.post9+e462414
source: heidelberg[Affiliation]
description: 'INTRODUCTION: In Multiple Sclerosis (MS), patients´ characteristics
  and (bio)markers that reliably predict the individual disease prognosis at disease
  onset are lacking. Cohort studies allow a close follow-up of MS histories and a
  thorough phenotyping of patients. Therefore, a multicenter cohort study was initiated
  to implement a wide spectrum of data and (bio)markers in newly diagnosed ...'
disable_comments: true
---
INTRODUCTION: In Multiple Sclerosis (MS), patients´ characteristics and (bio)markers that reliably predict the individual disease prognosis at disease onset are lacking. Cohort studies allow a close follow-up of MS histories and a thorough phenotyping of patients. Therefore, a multicenter cohort study was initiated to implement a wide spectrum of data and (bio)markers in newly diagnosed ...